AERI Annual CFF
$2.97 M
+$3.83 M+445.98%
31 December 2021
Summary:
As of January 23, 2025, AERI annual cash flow from financing activities is $2.97 million, with the most recent change of +$3.83 million (+445.98%) on December 31, 2021. During the last 3 years, it has fallen by -$134.06 million (-97.83%).AERI Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AERI Quarterly CFF
$188.00 K
+$22.00 K+13.25%
30 September 2022
Summary:
As of January 23, 2025, AERI quarterly cash flow from financing activities is $188.00 thousand, with the most recent change of +$22.00 thousand (+13.25%) on September 30, 2022. Over the past year, it has increased by +$578.00 thousand (+148.21%).AERI Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AERI TTM CFF
$3.38 M
+$578.00 K+20.60%
30 September 2022
Summary:
As of January 23, 2025, AERI TTM cash flow from financing activities is $3.38 million, with the most recent change of +$578.00 thousand (+20.60%) on September 30, 2022. Over the past year, it has increased by +$3.40 million (+17910.53%).AERI TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AERI Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +446.0% | +148.2% | +10000.0% |
| 3 y3 years | -97.8% | -99.9% | -98.8% |
| 5 y5 years | -97.8% | +138.0% | -98.8% |
AERI Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -98.9% | -99.9% | -98.8% |
Aerie Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $188.00 K(+13.3%) | $3.38 M(+20.6%) |
| June 2022 | - | $166.00 K(-146.5%) | $2.81 M(-24.5%) |
| Mar 2022 | - | -$357.00 K(-110.5%) | $3.72 M(+25.0%) |
| Dec 2021 | $2.97 M(-446.0%) | $3.39 M(-968.5%) | $2.97 M(<-9900.0%) |
| Sept 2021 | - | -$390.00 K(-136.2%) | -$19.00 K(-106.9%) |
| June 2021 | - | $1.08 M(-197.7%) | $276.00 K(-151.3%) |
| Mar 2021 | - | -$1.10 M(-378.0%) | -$538.00 K(-37.4%) |
| Dec 2020 | -$859.00 K(-100.3%) | $396.00 K(-516.8%) | -$859.00 K(+4.1%) |
| Sept 2020 | - | -$95.00 K(-136.3%) | -$825.00 K(-100.3%) |
| June 2020 | - | $262.00 K(-118.4%) | $274.87 M(+0.4%) |
| Mar 2020 | - | -$1.42 M(-430.7%) | $273.75 M(-0.4%) |
| Dec 2019 | $274.80 M(+100.5%) | $430.00 K(-99.8%) | $274.80 M(+0.1%) |
| Sept 2019 | - | $275.60 M(<-9900.0%) | $274.66 M(<-9900.0%) |
| June 2019 | - | -$856.00 K(+130.1%) | -$1.47 M(-162.5%) |
| Mar 2019 | - | -$372.00 K(-229.6%) | $2.35 M(-98.3%) |
| Dec 2018 | $137.04 M(+1.0%) | $287.00 K(-154.3%) | $137.04 M(-8.4%) |
| Sept 2018 | - | -$529.00 K(-117.8%) | $149.60 M(-0.4%) |
| June 2018 | - | $2.96 M(-97.8%) | $150.21 M(-44.3%) |
| Mar 2018 | - | $134.31 M(+944.9%) | $269.91 M(+99.0%) |
| Dec 2017 | $135.64 M | $12.85 M(>+9900.0%) | $135.64 M(+9.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | $79.00 K(-99.9%) | $123.56 M(-57.3%) |
| June 2017 | - | $122.66 M(>+9900.0%) | $289.17 M(+71.6%) |
| Mar 2017 | - | $48.00 K(-93.8%) | $168.54 M(-0.0%) |
| Dec 2016 | $168.63 M(+225.3%) | $768.00 K(-99.5%) | $168.63 M(-1.5%) |
| Sept 2016 | - | $165.69 M(+8042.2%) | $171.22 M(+830.9%) |
| June 2016 | - | $2.04 M(+1489.8%) | $18.39 M(+8.9%) |
| Mar 2016 | - | $128.00 K(-96.2%) | $16.90 M(-67.4%) |
| Dec 2015 | $51.84 M(-57.8%) | $3.36 M(-73.9%) | $51.84 M(+9.7%) |
| Sept 2015 | - | $12.87 M(+2291.4%) | $47.25 M(-70.2%) |
| June 2015 | - | $538.00 K(-98.5%) | $158.51 M(+0.3%) |
| Mar 2015 | - | $35.07 M(-2962.9%) | $157.99 M(+28.5%) |
| Dec 2014 | $122.98 M(+47.8%) | -$1.23 M(-101.0%) | $122.98 M(-36.7%) |
| Sept 2014 | - | $124.13 M(>+9900.0%) | $194.15 M(+154.6%) |
| June 2014 | - | $9000.00(-86.2%) | $76.26 M(-5.0%) |
| Mar 2014 | - | $65.00 K(-99.9%) | $80.30 M(-3.5%) |
| Dec 2013 | $83.23 M(+2794.1%) | $69.95 M(+1020.6%) | $83.23 M(+526.4%) |
| Sept 2013 | - | $6.24 M(+54.3%) | $13.29 M(+88.6%) |
| June 2013 | - | $4.05 M(+34.9%) | $7.05 M(+134.9%) |
| Mar 2013 | - | $3.00 M | $3.00 M |
| Dec 2012 | $2.88 M(-87.9%) | - | - |
| Dec 2011 | $23.85 M | - | - |
FAQ
- What is Aerie Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Aerie Pharmaceuticals?
- What is Aerie Pharmaceuticals annual CFF year-on-year change?
- What is Aerie Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Aerie Pharmaceuticals?
- What is Aerie Pharmaceuticals quarterly CFF year-on-year change?
- What is Aerie Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Aerie Pharmaceuticals?
- What is Aerie Pharmaceuticals TTM CFF year-on-year change?
What is Aerie Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of AERI is $2.97 M
What is the all time high annual CFF for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high annual cash flow from financing activities is $274.80 M
What is Aerie Pharmaceuticals annual CFF year-on-year change?
Over the past year, AERI annual cash flow from financing activities has changed by +$3.83 M (+445.98%)
What is Aerie Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of AERI is $188.00 K
What is the all time high quarterly CFF for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high quarterly cash flow from financing activities is $275.60 M
What is Aerie Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, AERI quarterly cash flow from financing activities has changed by +$578.00 K (+148.21%)
What is Aerie Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of AERI is $3.38 M
What is the all time high TTM CFF for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high TTM cash flow from financing activities is $289.17 M
What is Aerie Pharmaceuticals TTM CFF year-on-year change?
Over the past year, AERI TTM cash flow from financing activities has changed by +$3.40 M (+17910.53%)